Vaccine

Doses

Recommendation

Comment

Measles-mumpsrubella (MMR)

One or two doses

High-risk groups such as college students, healthcare workers, and international travelers should receive two doses; others should receive one dose.

Adults born before 1956 have innate immunity and do not require vaccine.

Tetanus-diphtheria and tetanus-reduced diphtheria-acellular pertussis (Tdap)

Td every 10 years

All adults should receive a Td every 10 years after completion of primary series.

Adults ages 19 to 64 should receive a single dose of Tdap in place of a Td booster if their last dose of Td was 10 years previously or earlier.

Influenza

One dose every year

All adults every year

Allergic hypersensitivity to egg proteins is a contraindication for vaccine.

Pneumococcal vaccine, polysaccharide^a

One or two doses

• 
  

  All adults age ≥65 years of age

  
  
• 
  

  Adults 19 through 64 years of age who are smokers or have asthma or any long-term health conditions

  
  
• 
  

  Residents of nursing homes or long-term care facilities

A second dose is recommended for people 65 years and older who got their first dose when they were younger than 65 and it has been 5 or more years since the first dose.

Varicella

Two doses 28 days apart

High-risk adults who never had chickenpox or not received chickenpox vaccine

Healthcare professionals, teachers, child-care workers, residents and staff in the long-term care facilities, nonpregnant women of childbearing age, college students

Zoster vaccine

Single dose

Adults 60 years old or older, whether or not the patient reported a prior episode of shingles. Persons with chronic medical conditions may be vaccinated unless a contraindication or precaution exists for their condition.

Not if allergic to neomycin and gelatin, immunocompromised pts, pregnant women, active untreated tuberculosis (until resolved), children, or adolescents

Hepatitis A

Two-dose series

Adults in high-risk groups

High-risk group that includes international travelers, residents of communities with high rates of infection (Native Americans, Alaskan natives, and Pacific Islanders), homosexual and bisexual men, injection-drug users, persons with chronic liver disease, and food handlers

Hepatitis B

Three-dose series at 0, 1, and 6 months

Universal infant vaccination and catch-up vaccination of nonimmune older children, adolescents, and high-risk individuals

High-risk groups include healthcare workers, residents and staff of long-term care facilities or prisons, homosexual or bisexual men or heterosexuals with multiple partners, injection-drug users, recipients of clotting factor concentrates, household or sexual contacts of HBV carriers.

HPV vaccine

Three doses series at 0, 1, and 6 months

For girls ages 11-12 years, with catch-up vaccination for girls and women ages 13-26 years

Advisory Committee on Immunization Practices (ACIP) provided guidance that HPV4 may be given to males aged 9 through 26 years to reduce their likelihood of acquiring genital warts; ACIP does not recommend HPV4 for routine use among males.

Meningococcal vaccine

Two doses. The first dose at 11 or 12 years of age, with a booster dose at age 16

Adolescents 11 through 18 years of age, college freshmen living in dormitories, microbiologists who are routinely exposed to isolates of Neisseria meningitidis, military recruits, people who have terminal complement component deficiencies and have anatomic or functional asplenia

Covers serogroups A, C, Y, and W-135, but not B

^a The FDA approved a 13-valent, conjugate pneumococcal vaccine for adults >50 in December 2011 but this has not been added to the vaccine schedule to date.